Corpus Intelligence IC Memo — REGIONAL REHABILITATION HOSPITAL 2026-04-26 14:09 UTC
IC Memo — REGIONAL REHABILITATION HOSPITAL
Investment Committee Memorandum | AL | 58 beds | Grade C | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

REGIONAL REHABILITATION HOSPITAL

CCN 013033 | RUSSELL, AL | 58 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

REGIONAL REHABILITATION HOSPITAL is a 58-bed community hospital in RUSSELL, AL with $33.3M in net patient revenue and a 34.2% operating margin. The hospital serves a payer mix of 71.6% Medicare, 0.0% Medicaid, and 28.4% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 34.2% to 41.6% (+736bps).

Net Revenue HCRIS$33.3M
Current EBITDA COMPUTED$11.4M
Operating Margin COMPUTED34.2%
Occupancy HCRIS98.4%
Revenue / Bed COMPUTED$574K
Net-to-Gross HCRIS71.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
59
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of 34.2% places it above the state median. Among 59 size-comparable peers (29-116 beds), the median margin is -14.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (29-116), prioritizing same-state peers. 59 hospitals in the comp set.

HospitalStateBedsRevenueMargin
REGIONAL REHABILITATION HOSPIT (Target)AL58$33.3M34.2%
SOUTH BALDWIN REGIONAL MEDICALAL112$168.2M46.4%
ATHENS LIMESTONEAL66$88.9M-20.9%
BRYCE HOSPITALAL98$76.4M29.5%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
VAUGHAN REGIONAL MEDICAL CENTEAL109$63.0M-4.8%
MEDICAL CENTER ENTERPRISEAL99$59.1M1.6%
EASTPOINTE HOSPITALAL66$56.6M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$699K+210bp18mo
Cost to Collect4.5%2.5%$666K+200bp12mo
Denial Rate Reduction12.0%6.5%$660K+198bp12mo
A/R Days Reduction5200.0%3800.0%$405K+122bp9mo
Clean Claim Rate88.0%96.0%$21K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$699K
Cost to Collect
$666K
Denial Rate Reduction
$660K
A/R Days Reduction
$405K
Clean Claim Rate
$21K
Total EBITDA Uplift$2.5M
Current EBITDA$11.4M
+ RCM Uplift+$2.5M
Pro Forma EBITDA$13.8M
Current Margin34.2%
Pro Forma Margin41.6%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$17.5M$99.7M5.69x41.6%
Base (11x exit)10.0x11.0x$17.5M$115.3M6.58x45.8%
Bull Case9.0x11.0x$15.8M$129.1M8.18x52.3%
Bull (12x exit)9.0x12.0x$15.8M$145.5M9.22x56.0%
Bear Case11.0x10.0x$19.3M$81.7M4.24x33.5%
Bear (11x exit)11.0x11.0x$19.3M$96.2M4.99x37.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 71.6% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 59 hospitals with 29-116 beds
  • Same-state prioritization (n=60)
  • Comp margins: P25=-24.4% / P50=-14.2% / P75=5.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.